Prokarium

Prokarium company information, Employees & Contact Information

Explore related pages

Related company profiles:

Prokarium is pioneering the field of microbial immunotherapy. Our pipeline is designed to unlock the next level of immuno-oncology by building on the most recent advances in cancer immunology. Prokarium’s lead program is focused on transforming the treatment paradigm in bladder cancer by orchestrating immune-driven, long-lasting antitumor effects.

Company Details

Employees
19
Address
2 Royal College Street, London,england,united Kingdom
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
London, England
Looking for a particular Prokarium employee's phone or email?

Prokarium Questions

News

Prokarium Expands IP Portfolio With Two New U.S. Patents Strengthening Its Position in Bladder Cancer - Business Wire

Prokarium Expands IP Portfolio With Two New U.S. Patents Strengthening Its Position in Bladder Cancer Business Wire

Prokarium begins clinical trial of bladder cancer immunotherapy - Clinical Trials Arena

Prokarium begins clinical trial of bladder cancer immunotherapy Clinical Trials Arena

Prokarium bolsters IP portfolio with two new US patents - Pharmaceutical Technology

Prokarium bolsters IP portfolio with two new US patents Pharmaceutical Technology

Study launches exploring immunotherapy regimen in NMIBC - Urology Times

Study launches exploring immunotherapy regimen in NMIBC Urology Times

This Oral Vaccine for Typhoid Raises €8M from International Investors - Labiotech.eu

This Oral Vaccine for Typhoid Raises €8M from International Investors Labiotech.eu

Prokarium Achieves Milestone with First Patient Dosing in PARADIGM-1 Non-Muscle Invasive Bladder Cancer Clinical Trial - Via TT

Prokarium Achieves Milestone with First Patient Dosing in PARADIGM-1 Non-Muscle Invasive Bladder Cancer Clinical Trial Via TT

Prokarium Appoints Kristen Albright as Chief Executive Officer - Business Wire

Prokarium Appoints Kristen Albright as Chief Executive Officer Business Wire

Prokarium Acquires Emergent’s Oral Vaccine Technology - Contract Pharma

Prokarium Acquires Emergent’s Oral Vaccine Technology Contract Pharma

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant